Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Occupational Exposures in the Culinary Underbelly: Air Pollution in Restaurants.

Environmental science & technology·2026

Same author

Examining a link between gastroparesis and anxiety and depression: a brief contemporary review.

Explore (New York, N.Y.)·2026

Same author

Exposure to electronic cigarette aerosols triggers alterations in genomic DNA methylation that impacts cancer pathways in mice.

Inhalation toxicology·2026

Same author

Can AI substitute the first reader in chest radiograph screening? A retrospective non-inferiority evaluation.

Japanese journal of radiology·2026

Same author

Feasibility of Aorto-uni-iliac Endovascular Aortic Repair Using the Gore Excluder for Abdominal Aortic Aneurysm.

Interventional radiology (Higashimatsuyama-shi (Japan)·2025

Same author

A Case Report of a Postmortem Intrauterine Fetal Magnetic Resonance Imaging That Identified an Umbilical Cord Factor as the Cause of Fetal Death.

The journal of obstetrics and gynaecology research·2025

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8⁺ T Cell Responses

Published on: May 6, 2019

Tumor challenges in immunotoxicity testing.

Sheung Ng, Kotaro Yoshida, Judith T Zelikoff

Methods in Molecular Biology (Clifton, N.J.)

|December 8, 2009

Summary

Syngeneic murine tumor models, including EL4 lymphoma and B16F10 melanoma cells in C57BL/6 mice, are crucial for studying toxicant effects on tumor susceptibility. Researchers can utilize subcutaneous or intravenous injections to examine local or metastatic tumor development.

Area of Science:

Immunology
Toxicology
Oncology

Background:

Syngeneic murine tumor models are vital for investigating toxicant-induced alterations in tumor susceptibility.
Commonly employed models include EL4 mouse lymphoma and B16F10 mouse melanoma cells, typically in C57BL/6 mice.

Purpose of the Study:

To detail the materials and methodologies for utilizing syngeneic murine tumor models.
To provide a framework for assessing host resistance against transplanted tumors in vivo.

Main Methods:

Utilizing EL4 mouse lymphoma cells (derived from 9,10-dimethyl-1,2-benzanthracene-induced lymphoma) and B16F10 mouse melanoma cells (spontaneously arising).
Employing C57BL/6 mice or other strains like B(6)C(3)F(1) as syngeneic hosts.
Administering tumor cells via subcutaneous (local tumor development) or intravenous (experimental metastasis) injection.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8⁺ T Cells in Mice

Published on: June 12, 2021

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

Related Experiment Videos

Last Updated: Jun 18, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8⁺ T Cell Responses

Published on: May 6, 2019

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8⁺ T Cells in Mice

Published on: June 12, 2021

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

Main Results:

The abstract describes established protocols for syngeneic tumor model implementation.
It outlines methods for evaluating tumor susceptibility and host resistance.

Conclusions:

Syngeneic murine tumor models offer a robust platform for toxicological and immunological research.
Standardized methodologies ensure reliable assessment of tumor development and metastasis in response to toxicants.